Drug Shortage Report for ODAN PROCTOMYXIN HC
Report ID | 89417 |
Drug Identification Number | 02242527 |
Brand name | SANDOZ PROCTOMYXIN HC |
Common or Proper name | PROCTOMYXIN |
Company Name | ODAN LABORATORIES LTD |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN |
Strength(s) | 5MG 5MG 10MG 10MG |
Dosage form(s) | OINTMENT |
Route of administration | RECTAL |
Packaging size | 15G |
ATC code | C05AA |
ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-07-03 |
Estimated end date | 2020-01-31 |
Actual end date | 2020-01-20 |
Shortage status | Resolved |
Updated date | 2020-02-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2020-02-15 | French | Compare |
v9 | 2020-02-15 | English | Compare |
v8 | 2019-11-06 | French | Compare |
v7 | 2019-11-06 | English | Compare |
v6 | 2019-10-15 | French | Compare |
v5 | 2019-10-15 | English | Compare |
v4 | 2019-08-21 | French | Compare |
v3 | 2019-08-21 | English | Compare |
v2 | 2019-07-16 | French | Compare |
v1 | 2019-07-16 | English | Compare |
Showing 1 to 10 of 10